C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer

Oncotarget

Volumn 6, Issue 19, 2015, Pages 17430-17444

  Martens Uzunova, Elena S ^a   Hoogstrate, Youri ^a   Kalsbeek, Anton ^a   Pigmans, Bas ^a   Vredenbregt van den Berg, Mirella ^a   Dits, Natasja ^a   Nielsen, Søren Jensby ^b,c   Baker, Adam ^b,d   Visakorpi, Tapio ^e   Bangma, Chris ^a   Jenster, Guido ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Exiqon AS   (Denmark)

^c Nuevolution A/S   (Denmark)

^d CHR HANSEN A S   (Denmark)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

GAS5; Prostate cancer; SdRNA; SNORD78; snoRNA

Indexed keywords

C/D BOX SMALL NUCLEOLAR RNA DERIVED RNA; MICRORNA; SMALL NUCLEOLAR RNA; SMALL UNTRANSLATED RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; POLYMERASE CHAIN REACTION; PROSTATE CANCER; RNA SEQUENCE; RNA SYNTHESIS; SNORD44 GENE; SNORD74 GENE; SNORD78 GENE; SNORD81 GENE; CELL TRANSFORMATION; DISEASE COURSE; GENETICS; PATHOLOGY; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION;

CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL NUCLEOLAR; UP-REGULATION;

EID: 84938233591     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4172     Document Type: Article

References (50)

1. Iorio MV and Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012; 4:143-159.
2. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T and Visakorpi T. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011; 59:671-681.
3. Martens-Uzunova ES, Jalava SE, Dits NF, van Leenders GJ, Moller S, Trapman J, Bangma CH, Litman T, Visakorpi T and Jenster G. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene. 2012; 31:978-991.
4. Castle JC, Armour CD, Lower M, Haynor D, Biery M, Bouzek H, Chen R, Jackson S, Johnson JM, Rohl CA and Raymond CK. Digital genome-wide ncRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification. PLoS One. 2010; 5:e11779.
5. Soeno Y, Fujita K, Kudo T, Asagiri M, Kakuta S, Taya Y, Shimazu Y, Sato K, Tanaka-Fujita R, Kubo S, Iwakura Y, Nakamura Y, Mori S, et al. Generation of a Mouse Model with Down-Regulated U50 snoRNA (SNORD50) Expression and Its Organ-Specific Phenotypic Modulation. PLoS One. 2013; 8:e72105.
6. Goeze A, Schluns K, Wolf G, Thasler Z, Petersen S and Petersen I. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol. 2002; 196:8-16.
7. Mei YP, Liao JP, Shen J, Yu L, Liu BL, Liu L, Li RY, Ji L, Dorsey SG, Jiang ZR, Katz RL, Wang JY and Jiang F. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. 2012; 31:2794-2804.
8. Liao J, Yu L, Mei Y, Guarnera M, Shen J, Li R, Liu Z and Jiang F. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer. 2010; 9:198.
9. Ronchetti D, Mosca L, Cutrona G, Tuana G, Gentile M, Fabris S, Agnelli L, Ciceri G, Matis S, Massucco C, Colombo M, Reverberi D, Recchia AG, et al. Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia. BMC Med Genomics. 2013; 6:27.
10. Ronchetti D, Todoerti K, Tuana G, Agnelli L, Mosca L, Lionetti M, Fabris S, Colapietro P, Miozzo M, Ferrarini M, Tassone P and Neri A. The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma. Blood Cancer Journal. 2012; 2.
11. Valleron W, Laprevotte E, Gautier EF, Quelen C, Demur C, Delabesse E, Agirre X, Prosper F, Kiss T and Brousset P. Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia. 2012; 26:2052-2060.
12. Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A, Parrens M, Lamant L, de Leval L, Gisselbrecht C, Gaulard P and Brousset P. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood. 2012; 120:3997-4005.
13. Tanaka R, Satoh H, Moriyama M, Satoh K, Morishita Y, Yoshida S, Watanabe T, Nakamura Y and Mori S. Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells. 2000; 5:277-287.
14. Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W, Petros J, Li Q, Vessella RL, Kibel AS, Stevens VL, Calle EE and Dong JT. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet. 2008; 17:1031-1042.
15. Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W and Dong JT. Implication of snoRNA U50 in human breast cancer. J Genet Genomics. 2009; 36:447-454.
16. Xu G, Yang F, Ding CL, Zhao LJ, Ren H, Zhao P, Wang W and Qi ZT. Small nucleolar RNA 113-1 suppresses tumorigenesis in hepatocellular carcinoma. Mol Cancer. 2014; 13:216.
17. Chen LY, Han L, Wei JW, Zhang KL, Shi ZD, Duan R, Li SW, Zhou X, Pu PY, Zhang JN and Kang CS. SNORD76, a box C/D snoRNA, acts as a tumor suppressor in glioblastoma. Scientific Reports. 2015; 5.
18. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, Taylor M, Patil M, Sheldon H, Betts G, Homer J, West C, Ragoussis J and Harris AL. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer. 2011; 104:1168-1177.
19. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F and Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009; 28:195-208.
20. Martens-Uzunova ES, Olvedy M and Jenster G. Beyond microRNA - Novel RNAs derived from small non-coding RNA and their implication in cancer. Cancer Lett. 2013; 340:201-211.
21. Saraiya AA and Wang CC. snoRNA, a novel precursor of microRNA in Giardia lamblia. PLoS Pathog. 2008; 4:e1000224.
22. Taft RJ, Glazov EA, Lassmann T, Hayashizaki Y, Carninci P and Mattick JS. Small RNAs derived from snoRNAs. RNA. 2009; 15:1233-1240.
23. Brameier M, Herwig A, Reinhardt R, Walter L and Gruber J. Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res. 2011; 39:675-686.
24. Burroughs AM, Ando Y, de Hoon MJ, Tomaru Y, Suzuki H, Hayashizaki Y and Daub CO. Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin. RNA Biol. 2011; 8:158-177.
25. Ono M, Scott MS, Yamada K, Avolio F, Barton GJ and Lamond AI. Identification of human miRNA precursors that resemble box C/D snoRNAs. Nucleic Acids Res. 2011; 39:3879-3891.
26. Ender C, Krek A, Friedlander MR, Beitzinger M, Weinmann L, Chen W, Pfeffer S, Rajewsky N and Meister G. A human snoRNA with microRNA-like functions. Mol Cell. 2008; 32:519-528.
27. Scott MS, Avolio F, Ono M, Lamond AI and Barton GJ. Human miRNA precursors with box H/ACA snoRNA features. PLoS Comput Biol. 2009; 5:e1000507.
28. Kishore S, Gruber AR, Jedlinski DJ, Syed AP, Jorjani H and Zavolan M. Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing. Genome Biol. 2013; 14:R45.
29. Kishore S, Khanna A, Zhang Z, Hui J, Balwierz PJ, Stefan M, Beach C, Nicholls RD, Zavolan M and Stamm S. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet. 2010; 19:1153-1164.
30. Shen M, Eyras E, Wu J, Khanna A, Josiah S, Rederstorff M, Zhang MQ and Stamm S. Direct cloning of double-stranded RNAs from RNase protection analysis reveals processing patterns of C/D box snoRNAs and provides evidence for widespread antisense transcript expression. Nucleic Acids Res. 2011; 39:9720-9730.
31. Soeno Y, Taya Y, Stasyk T, Huber LA, Aoba T and Huttenhofer A. Identification of novel ribonucleo-protein complexes from the brain-specific snoRNA MBII-52. RNA. 2010; 16:1293-1300.
32. Scott MS, Ono M, Yamada K, Endo A, Barton GJ and Lamond AI. Human box C/D snoRNA processing conservation across multiple cell types. Nucleic Acids Res. 2012; 40:3676-3688.
33. Schubert T, Pusch MC, Diermeier S, Benes V, Kremmer E, Imhof A and Langst G. Df31 protein and snoRNAs maintain accessible higher-order structures of chromatin. Mol Cell. 2012; 48:434-444.
34. Koppers-Lalic D, Hackenberg M, Bijnsdorp IV, van Eijndhoven MA, Sadek P, Sie D, Zini N, Middeldorp JM, Ylstra B, de Menezes RX, Wurdinger T, Meijer GA and Pegtel DM. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 2014; 8:1649-1658.
35. von Ahlfen S, Missel A, Bendrat K and Schlumpberger M. Determinants of RNA quality from FFPE samples. PLoS One. 2007; 2:e1261.
36. Liu A, Tetzlaff MT, Vanbelle P, Elder D, Feldman M, Tobias JW, Sepulveda AR and Xu X. MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int J Clin Exp Pathol. 2009; 2:519-527.
37. Larne O, Martens-Uzunova E, Hagman Z, Edsjo A, Lippolis G, den Berg MS, Bjartell A, Jenster G and Ceder Y. miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer. 2013; 132:2867-2875.
38. Hoogstrate Y, Jenster G and Martens-Uzunova ES. FlaiMapper: computational annotation of small ncRNA derived fragments using RNA-seq high throughput data. Bioinformatics. 2015; 31:665-673.
39. Kozomara A and Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011; 39:D152-157.
40. Leung YY, Ryvkin P, Ungar LH, Gregory BD and Wang LS. CoRAL: predicting non-coding RNAs from small RNA-sequencing data. Nucleic Acids Res. 2013; 41:e137.
41. Bortolin-Cavaille ML and Cavaille J. The SNORD115 (H/MBII-52) and SNORD116 (H/MBII-85) gene clusters at the imprinted Prader-Willi locus generate canonical box C/D snoRNAs. Nucleic Acids Res. 2012; 40:6800-6807.
42. Smith CM and Steitz JA. Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol. 1998; 18:6897-6909.
43. Kiss-Laszlo Z, Henry Y and Kiss T. Sequence and structural elements of methylation guide snoRNAs essential for site-specific ribose methylation of pre-rRNA. EMBO J. 1998; 17:797-807.
44. Lapinaite A, Simon B, Skjaerven L, Rakwalska-Bange M, Gabel F and Carlomagno T. The structure of the box C/D enzyme reveals regulation of RNA methylation. Nature. 2013; 502:519-523.
45. Li Z, Ender C, Meister G, Moore PS, Chang Y and John B. Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs. Nucleic Acids Res. 2012; 40:6787-6799.
46. Cifuentes D, Xue H, Taylor DW, Patnode H, Mishima Y, Cheloufi S, Ma E, Mane S, Hannon GJ, Lawson ND, Wolfe SA and Giraldez AJ. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science. 2010; 328:1694-1698.
47. Wright MW and Bruford EA. Naming 'junk': human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics. 2011; 5:90-98.
48. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM and Haussler D. The human genome browser at UCSC. Genome Res. 2002; 12:996-1006.
49. Lowe TM and Eddy SR. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 1997; 25:955-964.
50. Kal AJ, van Zonneveld AJ, Benes V, van den Berg M, Koerkamp MG, Albermann K, Strack N, Ruijter JM, Richter A, Dujon B, Ansorge W and Tabak HF. Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. Mol Biol Cell. 1999; 10:1859-1872.